1. Prevalence of left main coronary artery disease among patients referred to multislice computed tomography coronary examinations. Gemici G, Guneysu T, Eroğlu E, Bayrak F, Sevinc D, Aytaclar S, Kaya Z, Mutlu B, Degertekin M.
2. Echocardiographic predictors of severe heart failure symptoms in hypertrophic cardiomyopathy patients with sinus rhythmBayrak F, Kahveci G, Degertekin M, Mutlu BTrials. 2008 Feb 29; 9: 11
3rdDiagnostic performance of 64-slice stenosis.computed tomography coronary angiography to detect significant coronary arteryBayrak F, Guneysu T, Gemici G, Sevinc D, Mutlu B, Aytaclar S, Degertekin M. Acta Cardiol. 2008 Feb; 63 (1): 11-7
4.Tissue Doppler imaging to predict the clinical course of patients with hypertrophic cardiomyopathy.Bayrak F, Kahveci G, Mutlu B, Sonmez K, Degertekin Eur J Echocardiogr. 2008 Mar; 9 (2): 278-83.
5.Safety and efficacy of patient preparation with intravenous esmolol before 64-slice computed tomography coronary angiography.Degertekin M, Gemici G, Kaya Z, Bayrak Guneysu T, Sevinc D, Mutlu B, Aytaçlar S. Coron Artery Dis. 2008 Feb; 19 (1): 33-6.
6. Prognostic value of N-terminal pro-B-type natriuretic peptide in patients with active infective endocarditis.Kahveci G, Bayrak F, Mutlu B, Bitigen A, Karaahmet T, Sonmez K, Izgi A, Degertekin M, Basaran Y. Am J Cardiol. 2007 May 15; 99 (10): 1429-33. Epub 2
7. Can multidetector CT angiography detect coronary artery dissection? Vural M, Aksit Z, Kovanlikaya I, Degertekin M, Demirtas E. Texas Heart Inst J. 2007; 34 (3): 388-9.
8.The usefulness of N-terminal pro-B-type natriuretic peptide to predict clinical course in patients with hypertrophic cardiomyopathy. Mutlu B, Bayrak F, Kahveci G, Degertekin M, Eroglu E, Basaran Y.Am J Cardiol. 2006 Dec 1; 98 (11): 1504-6. Epub 2006 Oct 12
9.Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare-metal stents: insights from the randomized TAXUS II trial.Tanabe K, Serruys PW, Degertekin M, Grube E, Guagliumi G, Urbaszek W, Bonnier J, Lablanche JM, Seminyak T, Nord
10. In-hospital versus out-of-hospital cardiac arrest complicating myocardial infarction: survival after percutaneous coronary revascularization. Lee CH, Lemos PA, Degertekin M, Saia F, Tanabe K, Serruys PW. (Int J Cardiol. 2005 Feb 15; 98 (2): 359-60.)
11. Routine sirolimus-eluting stent implantation for unselected in-stent restenosis: insights from the rapamycin eluting stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry.Saia F, Lemos PA, Arampatzis CA, Hoye A, Degertekin M, Tanabe K, S
12. Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings. Tanabe K, Hoye A, Lemos PA, Aoki J, Arampatzis CA, Saia F, Lee CH, Degertekin M, Hofma SH, Sianos G, McFadden E, Smits PC, van der Giessen WJ, de Feyt
13.Effectiveness of sirolimus-eluting stent implantation for coronary narrowings <50% in diameter hole A, Lemos PA, Arampatzis CA, Saia F, Tanabe K, Degertekin M, Daemen J, Smits PC, McFadden E, Hofma SH, Sianos G, de Feyter P, van der Giessen WJ, van Do
14. Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo Narrowings Tanabe K, Hoye A, Lemos PA, Arampatzis CA, Saia F, Lee CH, Degertekin M, Hofma SH, Sianos G, McFadden E, Smits PC, van der Giessen WJ, de Feyter P, VA
15.Very Long Sirolimus-Eluting Stent Implantation for de novo Coronary LesionsDegertekin M, Arampatzis A, Lemos P, Saia F, Hoye A, Tanabe K, Daemen J, Liu TK, McFadden E, Sianos G, Hofma SH, Smits PC, Van Der Giessen WJ, De Feyter P, Serruys PW. (Am J Card
...
Read Less